Stanley He

Stanley Stanley currently serves as the Global Analytics & Insights Associate Director at AstraZeneca since August 2024. Concurrently, Stanley has been an Investor at Taskade since December 2018, contributing to the development of a collaboration tool for the distributed workforce, and the company was part of the Y Combinator S19 Batch. Previous roles include Chief Business Officer at RNAimmune from June 2020 to August 2024, Business Development at Sirnaomics, Inc. from November 2019 to June 2020, and Healthcare Investment at Sigma Square Capital in April 2018. Prior experience also includes serving as a Private Equity Investment Associate at PRINCIPLE CAPITAL LTD, a Business Systems Analyst at American Express, a Project Manager at Wearable X, and a Business Development Manager at BloomSky, Inc. Stanley holds an MBA from Georgetown University McDonough School of Business and a BS from Babson College.